New York policy
S9221: Establishes a medetomidine, benzodiazepine, nitazenes, and/or other harmful contaminants test strip program
NY Senate · Sponsor Christopher Ryan
- Jurisdiction
- New York State
- Applies to
- New York State (proposed)
- Effective
- June 4, 2026
What it requires
Directs the commissioner of the office of alcoholism and substance abuse services to establish a program for individuals to receive free drug test strips to detect the presence of medetomidine, benzodiazepine, nitazenes, and/or other harmful contaminants; directs the commissioner of the office of alcoholism and substance abuse services, in cooperation with the commissioner of the department of health, to develop and conduct a public awareness and educational campaign on the dangers of medetomidine, benzodiazepine, nitazenes, and/or other harmful contaminants.
Free account
Create a free account
Track New York policy and save searches across the Network. Free. No card required.
Want to turn policy like this into market and network moves? Build your Market Network Strategic Plan →
